HALE DAVID F 4
4 · Oncternal Therapeutics, Inc. · Filed Jun 24, 2024
Insider Transaction Report
Form 4
HALE DAVID F
Director
Transactions
- Award
Stock Options
2024-06-20+3,300→ 3,300 totalExercise: $8.10Exp: 2034-06-20→ Common Stock (3,300 underlying)
Footnotes (1)
- [F1]One-twelfth of the number of shares subject to the option vest and become exercisable in substantially equal installments on each monthly anniversary of the grant date, subject to the Reporting Person's continued service through such vesting date.